BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17805535)

  • 1. Extramedullary relapse of therapy-related myelodysplastic syndrome after donor leukocyte infusion.
    Chao MM; Kontny U; Brink I; Göhring G; Schmitt-Gräff A; Rister M; Strahm B
    Ann Hematol; 2008 Feb; 87(2):165-6. PubMed ID: 17805535
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations.
    Gassas A; Sung L; Saunders EF; Doyle J
    Bone Marrow Transplant; 2007 Nov; 40(10):951-5. PubMed ID: 17873916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation.
    Loren AW; Porter DL
    Bone Marrow Transplant; 2008 Mar; 41(5):483-93. PubMed ID: 18026156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extramedullary relapse of acute lymphoblastic leukemia in the breast after allogeneic stem cell transplantation and concomitant persistence of donor hematopoiesis.
    Manna A; Magli T
    Haematologica; 2001 Jul; 86(7):767-8. PubMed ID: 11454536
    [No Abstract]   [Full Text] [Related]  

  • 5. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favourable response to antithymocyte globulin therapy in resistant acute graft-versus-host disease.
    Tagliabue A; Corti P; Viganò E; Bonanomi S; Uderzo C
    Bone Marrow Transplant; 2005 Sep; 36(5):459. PubMed ID: 15980883
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias.
    Bader P; Dückers G; Kreyenberg H; Hoelle W; Kerst G; Lang P; Greil J; Niethammer D; Beck LF; Klingebiel T
    Ann Hematol; 2002; 81 Suppl 2():S25-7. PubMed ID: 12611064
    [No Abstract]   [Full Text] [Related]  

  • 9. Donor cell-derived leukemia and myelodysplastic neoplasm: unique forms of leukemia.
    Sala Torra O; Loeb KR
    Am J Clin Pathol; 2011 Apr; 135(4):501-4. PubMed ID: 21411772
    [No Abstract]   [Full Text] [Related]  

  • 10. Generalized vitiligo after allogeneic bone marrow transplantation.
    Cho SB; Roh MR; Chung KY; Lee KH; Park YK
    Acta Derm Venereol; 2005; 85(1):82-3. PubMed ID: 15849005
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimizing management of myelodysplastic syndromes post-allogeneic transplantation.
    Sockel K; Ehninger G; Hofbauer LC; Platzbecker U
    Expert Rev Hematol; 2011 Dec; 4(6):669-80. PubMed ID: 22077530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia/myelodysplastic syndrome: late CNS relapses despite graft-versus-host disease.
    Davies JK; Taussig DC; Oakervee H; Davies AJ; Agrawal SG; Gribben JG; Lister TA; Cavenagh JD
    J Clin Oncol; 2006 May; 24(14):e23-5. PubMed ID: 16682729
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon).
    Muñoz A; Diaz-Heredia C; Diaz MA; Badell I; Verdeguer A; Martinez A; Gomez P; Perez-Hurtado JM; Bureo E; Fernandez-Delgado R; Gonzalez-Valentin ME; Maldonado MS
    Pediatr Hematol Oncol; 2008 Jun; 25(4):245-59. PubMed ID: 18484470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
    Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant.
    Shaw BE; Russell NH
    Bone Marrow Transplant; 2008 Mar; 41(5):495-503. PubMed ID: 17952130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor cell-derived myelodysplastic syndrome after cord blood transplantation.
    Konuma T; Ooi J; Takahashi S; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Hongo E; Uchimaru K; Tojo A; Asano S
    Bone Marrow Transplant; 2009 Mar; 43(5):429-31. PubMed ID: 18978827
    [No Abstract]   [Full Text] [Related]  

  • 17. Autologous blood pleurodesis for pneumothorax complicating graft-versus-host disease-related bronchiolitis obliterans.
    Chadwick C; Marven SM; Vora AJ
    Bone Marrow Transplant; 2004 Feb; 33(4):451-3. PubMed ID: 14716352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy-related myelodysplastic syndrome after allogeneic BMT: successful treatment by donor lymphocyte infusions.
    Roos-Weil D; Nguyen S; Uzunov M; Bories D; Chapiro E; Nguyen-Khac F; Vernant JP; Dhédin N
    Bone Marrow Transplant; 2010 Sep; 45(9):1471-3. PubMed ID: 20098458
    [No Abstract]   [Full Text] [Related]  

  • 19. Allogeneic stem cell transplantation for myelodysplastic syndrome.
    Barrett AJ; Savani BN
    Semin Hematol; 2008 Jan; 45(1):49-59. PubMed ID: 18179969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.